PROGRAM

Hall 1 / 10:35-10:55 / 2025.07.24

"International Contribution and the Dawn of a New Era"

Chair: Keiya Ozawa (Emeritus Professor, Jichi Medical University)
Speaker: Takashi Okada (Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo)

Hall 1/ 16:20-16:50 / 2025.07.23

“Future Prospects of Regenerative Medicine, Cell Therapy, and Gene Therapy in Japan”

Chair: Masahiro Toda (Dept. of Neurosurgery, Keio University); Hideki Mochizuki (Dept. of Neurology, Osaka University Graduate School of Medicine)
Speaker: Toshiharu Furukawa (Member of The House of Councillors. Law School and Medical School, Keio University / TMI Associates)

Hall 1 / 11:15-11:45 / 2025.07.25

“TBD”

Chair: Akihiro Kume (Support Center for Clinical Investigation, Jichi Medical University)
Speaker: Daisaku Sato (Ministry of Health, Labour and Welfare)

Hall 1 / 12:15-12:55 / 2025.07.23

“Bespoke Gene Therapy Consortium”

Chairs: Masafumi Onodera (Graduate School of Engineering, Osaka University); Teruhide Yamaguchi (Nihon Pharmaceutical University/ National Institute of Health Sciences)
Speaker: Philip J. Brooks (Division of Rare Diseases Research Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health)

Hall 1 / 09:35-10:25 / 2025.07.24

“Redefining Viral Gene Therapy: Autonomous Parvovirus Capsids for Enhanced Delivery, Tropism, and Safety”

Chairs: Hiroyuki Nakai (Dept. of Molecular and Medical Genetics, Oregon Health & Science University); Toshihiko Okazaki (Cell Processing Center, OSAKA University, School of Medicine)
Speaker: Sebastian Aguirre Kozlouski (Platform Development, Carbon Biosciences)

Hall 1 / 14:25-15:15 / 2025.07.24

“Immune reaction of AAV”

Chair: Shin-ichi Muramatsu (Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University)
Speaker: J. Fraser Wright (Kriya Therapeutics)

Hall 1 / 16:25-17:05 / 2025.07.24

“AAV Gene Therapy for Rare Genetic Diseases”

Chairs: Yoshikatsu Eto (Advanced Clinical Research Center & Asian LSD Center, Institute of Neurological disorders); Toya Ohashi (Development of Gene Therapy for Lysosomal Storage Diseases, The Jikei University School of Medicine)
Speaker: Guangping Gao (Li Weibo Institute for Rare Diseases Research, UMass Chan Medical School)

Hall 1 / 09:35-10:25 / 2025.07.25

“in vivo CAR-T”

Chairs: Jun-ichi Mineno (CDM Center, Takara Bio Inc.); Masato Yamamoto (Basic and Translational Research, University of Minnesota)
Speaker: Haig Aghajanian (Capstan Therapeutics)

Hall 1 / 12:45-13:25 / 2025.07.24

“Next-generation Strategies and Challenges in Gene Therapy for Muscular Dystrophies”

Chair: En Kimura (Cell and Gene therapy Development, Astellas Pharma Inc.）; Takashi Okada (Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Speaker: Jeffrey S. Chamberlain (University of Washington School of Medicine)

Hall 1 / 13:35-14:05 / 2025.07.23

“Gene and cell therapy in the central nervous system”

Chairs: Yasufumi Kaneda (Center for infectious Disease Education and Research, The University of Osaka); Koji Nishida (Dept. of Ophthalmology, The University of Osaka)
Speaker: Hideyuki Okano (Regenerative Medicine Research Center, Keio University)

Hall 2 / 13:35-14:05 / 2025.07.23

“Advances in Neurodegenerative Disease Research Using iPS Cells and Gene Editing”

Chairs: Yutaka Hanazono (Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University); Ryuichi Morishita (Dept. of Clinical Gene Therapy, Osaka University Medical School)
Speaker: Haruhisa Inoue (Center for iPS Cell Research and Application (CiRA), Kyoto University)

Hall 1 / 10:35-11:05 / 2025.07.25

“Oncolytic virus therapy using herpes simplex virus type 1”

Chair: Kenzaburo Tani (Emeritus Professor, Kyushu University/ The Institute of Medical Science, The University of Tokyo)
Speaker: Tomoki Todo (Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo）

Hall 1 / 13:00-13:30 / 2025.07.23

“Fukuyama-type congenital muscular dystrophy”

Chairs: Shin-ichi Takeda (Dept. of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry); Torayuki Okuyama (Dept. of Clinical Genomics, Saitama Medical University)
Speaker: Tatsushi Toda (NCNP / Dept. of Neurology, Graduate School of Medicine, University of Tokyo)

Hall 2 / 12:45-13:25 / 2025.07.24

“Gene & cell therapy and regenerative medicine in future”

Chair: Rika Tanaka (Dept. of Plastic Surgery, Juntendo University Hospital)
Speaker: Takanori Takebe (Institute of Science Tokyo)
Panelist: Karin Kojima (Dept. of Pediatrics, Jichi Medical University)

Hall 2 / 16:10-16:50 / 2025.07.25

“Effects of Wine Tasting on Cognitive Function”

Chair: Takashi Okada (Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Speaker: Shinya Tasaki (Honorary president of ASI/ Honorary president of JSA)
Co-sponsor: Genesis Healthcare Co.

Hall 1 / 16:55-17:55 / 2025.07.23

Chairs: Takafumi Nakamura (Division of Genomic Medicine, Faculty of Medicine, Tottori University); Noriyuki Kasahara (Dept. of Neurological Surgery and Radiation Oncology, University of California, San Francisco)
Speakers: A: Matthew Porteus (Definitive and Curative Medicine, Stanford Medicine); E: Juan A. Bueren (CIEMAT and Biomedical Network Centre for Research on Rare Diseases, CIBERER); J: Toshiyoshi Fujiwara (Dept. of Gastrenterlogical Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.)

Hall 2 / 12:15-13:30 / 2025.07.23
The Japanese Society for Virology / JSGCT Joint Symposium
“Exploration of Next-Generation Viral Vectors for Innovative Technologies”

Chairs: Kohnosuke Mitani (Research Center for Genome Medicine, Saitama Medical University); Keizo Tomonaga (Laboratory of RNA viruses, Institute for Life and Medical Sciences)
Speakers: Yuying Wang (Dept. of Microbiology, Graduate School of Medicine, The University of Tokyo); Takahiro Kawagishi (Dept. of Virology, Research Institute for Microbial Diseases); Youichi Suzuki (Dept. of Microbiology and Infection Control, Osaka Medical and Pharmaceutical University); Tomokazu Tamura (Dept. of Virology, Graduate School of Medical Sciences, Kyushu University)

Hall 1 / 14:10-15:10 / 2025.07.23
The Japanese Society for Regenerative Medicine / JSGCT Joint Symposium
“TBD”

Chairs: Masahiro Toda (Dept. of Neurosurgery, Keio University School of Medicine); Katsuto Tamai (The University of Osaka Graduate School of Medicine)
Speakers: Miki Ando (Dept. of Hematology, Juntendo University School of Medicine); Yuki Kagoya (Institute for Advanced Medical Research, Keio University School of Medicine); Yoshikazu Yonemitsu (Kyushu University Graduate School of Pharmaceutical Sciences)

Hall 2 / 14:10-15:10 / 2025.07.23
The Japanese Society for Vaccinology / JSGCT Joint Symposium
“Frontline of accelerating next-generation vaccine development”

Chairs: Takaji Wakita (Japan Institute for Health Security); Takafumi Nakamura (Division of Genomic Medicine, Faculty of Medicine, Tottori University)
Speakers: Takao Hashiguchi (Lab. of Medical Virology, Institute for Life and Medical Sciences, Kyoto University); Ken Sugo (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo); Yoshimasa Takahashi (Research Center for Vaccine Development, Japan Institute for Health Security, National Institute of Infectious Diseases); Hironori Nakagami (Dept. of Health Development and Medicine, Osaka University Graduate School of Medicine); Ken Ishii (The Institute of Medical Science, The University of Tokyo)

Hall 2 / 09:35-10:35 / 2025.07.24
The Japanese Society of Child Neurology / JSGCT Joint Symposium
“Advancing Gene Therapy for Pediatric Diseases: From Discovery to Clinical Translation”

Chairs: Hitoshi Osaka (Dept. of Pediatrics, Jichi Medical School); Mariko Okubo (Dept. of Human Genetics, National Center for Global health and Medicine, Research Institute)
Speakers: Mariko Taniguchi-Ikeda (Dept. of Pediatrics, Kochi Medical School); Takeshi Yoshida (Dept. of Pediatrics, Kyoto University Graduate School of Medicine); Keiko Ishigaki (Dept. of Pediatrics, Tokyo Women's Medical University School of Medicine)

Hall 2 / 09:35-10:35 / 2025.07.25
Japanese Society for Genetic Counseling / JSGCT Joint Symposium
“The intersection between Gene ＆ Cell Therapy and genetic medicine/genetic counseling”

Chairs: Reiko Arakawa (Dept. of Genomic Medicine, National Center for Global Health and Medicine); Atsushi Watanabe (Division of Clinical Genetics / Support Center for Medical Genetics, Kanazawa University Hospital)
Speakers: Noriko Miyake (Dept. of Human Genetics, National Center for Global Health and Medicine); Masayoshi Nakakuni (Gene ＆ Cell Therapy Promotion Center, National Center for Child Health and Development); Kaori Muto (Dept. of Public Policy, Human Genome Center, The Institute of Medical Science, The University of Tokyo)

Hall 2 / 10:40-11:50 / 2025.07.25
Nucleic Acids Therapeutics Society of Japan / JSGCT Joint Symposium
“TBD”

Chairs: Takanori Yokota (NucleoTIDE and PepTIDE Drug Discovery Center, INSTITUTE OF SCIENCE TOKYO); Kumiko Ui-Tei (NucleoTIDE and PepTIDE Drug Discovery Center, INSTITUTE OF SCIENCE TOKYO)
Speakers: Masatora Fukuda (Dept. of Chemistry, Faculty of Science, Fukuoka University); Yousuke Katsuda (Faculty of Advanced Science and Technology, Kumamoto University); Hiroshi Abe (Dept. of Chemistry, Graduate School of Science, Nagoya University); Mariko Taniguchi-Ikeda (Dept. of Pediatrics, Kochi Medical School, Kochi University)

Hall 1 / 15:50-16:50 / 2025.07.25
The Japanese Society for Genome / JSGCT Joint Symposium
“Genome Editing and the Future of Next-Generation Medicine”

Chairs: Hironori Nakagami (University of Osaka Graduate School of Medicine); Tsukasa Ohmori (Center for Gene Therapy Research, Jichi Medical University)
Speakers: Tomoji Mashimo (Division of Animal Genetics, University of Tokyo Institute of Medical Science); Makoto Saito (Biophenomena Engineering RIKEN ECL Research Team, RIKEN); Yusuke Sato (Hokkaido University Faculty of Pharmaceutical Sciences); Takao Inoue (Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences)

Hall 2 / 16:55-17:55 / 2025.07.23
“Neurology”

Chairs: Chikako Nito (Laboratory for Clinical Research, Nihon Medical School); Seiichi Nagano (Dept. of Neurology, Osaka University, Graduate School of Medicine)
Speakers: Kazusaku Kamiya (Dept. of Otorhinolaryngology, Juntendo University); Hirokazu Hirai (Dept. of Neurophysiology & Neural Repair, Gunma University); Yoshihide Sehara (Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University)

Hall 2 / 14:25-15:25 / 2025.07.24
“Oncolytic virotherapy”

Chairs: Ken-ichiro Kosai (Dept. of Gene Therapy and Regenerative Medicine, Kagoshima University); Hiroshi Fukuhara (Dept. of Urology, Kyorin University School of Medicine)
Speakers: Hiroshi Fukuhara (Dept. of Urology, Kyorin University School of Medicine); Chieko Kai (Teikyo University Advanced Comprehensive Research Organization); Takafumi Nakamura (Faculty of Medicine, Division of genomic Medicine, Tottori University); Ken-ichiro Kosai (Dept. of Gene Therapy and Regenerative Medicine, Kagoshima University)

Hall 2 / 16:25-17:25 / 2025.07.24
“Endocrine and metabolic disease”

Chairs: Hiroshi Kobayashi (Division of Gene Therapy, Research Center for Medical Sciences, The Jikei University School of Medicine); Toru Uchiyama (Division of Molecular Pathogenesis, National Center for Child Health and Development)
Speakers: Kazuhiro Muramatsu (Dept. of Pediatrics, Jichi Medical University); Hiroshi Kobayashi (Division of Gene Therapy, Research Center for Medical Sciences, The Jikei University School of Medicine); Tojo Nakayama (Institute of science Tokyo)

Hall 3 / 09:35-10:35 / 2025.07.25
“Vector Development (AAV&HBoV)”

Chairs: Hiroaki Mizukami (Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University); Hiroyuki Mizuguchi (Graduate School of Pharmaceutical Sciences, Osaka University)
Speakers: Kaoru Seiriki (Graduate School of Pharmaceutical Sciences, The University of Osaka); Kenji Ohba (Center for Molecular Medicine, Division of Genetic Therapeutics, Jichi Medical University); Yuji Tsunekawa (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)

Hall 3 / 10:40-11:40 / 2025.07.25
“Ophthalmology”

Chairs: Tsutomu Igarashi (Dept. of Ophthalmology, Nippon Medical School Chiba Hokusoh Hospital); Yasuhiro Ikeda (Dept. of Medicine of Sensory and Motor Organs, Ophthalmology, University of Miyazaki)
Speakers: Yoshinori Oie (Dept. of Ophthalmology, Osaka University); Kaoru Fuinami (Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center); Yusaku Katada (Dept. of Ophthalmology, Keio University School of Medicine)

Hall 1 / 13:45-14:45 / 2025.07.25
“Duchenne muscular dystrophy and rare diseases”

Chairs: Takanori Yamagata (Tochigi Rehabilitation Center, Jichi Medical University); Yoshitsugu Aoki (Dept. of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry)
Speakers: Motoi Kanagawa (Graduate School of Medicine, Ehime University); Tomoki Kosho (Dept. of Medical Genetics, Shinshu University School of Medicine); Alex Murphy (Roche)

Hall 2 / 13:45-14:45 / 2025.07.25
“Cancer gene therapy”

Chairs: Yozo Nakazawa (Dept. of Pediatric, Shinshu University School of Medicine); Yoshikazu Yonemitsu (Kyushu University Graduate School of Pharmaceutical Sciences)
Speakers: Hiroshi Fujiwara (Dept. of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine); Ken Ohmine (Division of Hematology, Dept. of Medicine, Jichi Medical University); Yozo Nakazawa (Dept. of Pediatric, Shinshu University School of Medicine)

Hall 3 / 13:45-14:45 / 2025.07.25
“Young Investigators Session”

Chairs: Fuminori Sakurai (Dept. of Pharmacy, Kindai University); Takenori Yamamoto (Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences)
Speakers: Manaka Shinagawa (Dept. of Obstetrics and Gynecology, Shinshu University); Kiwako Tsukida (Center for Gene Therapy Research / Dept. of Pediatrics, Jichi Medical University); Tomoki Togashi (Dept. of Biochemistry, Jichi Medical University School of Medicine); Takenori Yamamoto (Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences)

Hall 3 / 15:50-16:50 / 2025.07.25
“Regulatory Science”

Chairs: Eriko Uchida (Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences); Akihiro Kume (Support Center for Clinical Investigation, Jichi Medical University)
Speakers: Hideyuki Hakui (Health Policy Bureau, Research and Development Policy Division, Ministry of Health, Labour and Welfare); Matsuo Eriko (Medical Science Division of Patent Examination Dept. (Chemistry, Life Science and Material Science), Japan Patent Office); Yoichi Yamamoto (Academic Clinical Research Center, Dept. of Medical Innovation, The University of Osaka Hospital)

Hall 1 / 10:15-11:05 / 2025.07.23

Chairs: Makoto Otsu (Kitasato University School of allied Health Science); Yumi Kanegae (AnGes, Inc.)

Hall 1 / 14:00-14:20 / 2025.07.24

Chairs: Takashi Okada (Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo); Ryuichi Morishita (Dept. of Clinical Gene Therapy, Osaka University Medical School)

Hall 3 / 12:45-13:10 / 2025.07.24

Chairs: Shin-ichi Muramatsu (Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University); Juan A. Bueren (CIEMAT and Biomedical Network Centre for Research on Rare Diseases, CIBERER)
Speakers: Takahiro Sato (Dept. of Biochemistry Jichi Medical University School of Medicine); Mizuho Takahashi (Division of Molecular and Medical Genetics Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo)

Hall 1 / 08:45-09:30 / 2025.07.24

Morning Seminar 1

Chair: Akihiro Okabe (Mitsui Chemicals, Inc.)
Speakers: “Introduction of Cell Culture Equipment Developed with Functional Materials for High Productivity”; Shoko Matsumura (Mitsui Chemicals, Inc.); “Mass Culture System Using Tidal Culture with Nonwoven Scaffold Materials”; Shunmei Chiba (FullStem Co., Ltd.)
Co-sponsor: Mitsui Chemicals, Inc.

Hall 2 / 08:45-09:30 / 2025.07.24

Morning Seminar 2

“The Present Landscape and Future Perspective of Process Development and Quality Analysis in Gene Therapy”

Chair: Tsukasa Ohmori (Dept. of Biochemistry, Jichi Medical University School of Medicine)
Speaker: Susumu Uchiyama (Dept. of Biotechnology, Graduate School of Engineering, The University of Osaka)
Co-sponsor: U-Medico Inc.

Hall 3 / 08:45-09:30 / 2025.07.24

Morning Seminar 3

“Potential gene therapy for Ehlers-Danlos Syndrome and quantitative evaluation of therapeutic vectors using the Octet® system”

Chair: Yusuke Maruyama (Sartorius Japan K.K.)
Speaker: Yuko Kasahara (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Co-sponsor: Sartorius Japan K.K.

Hall 1 / 08:45-09:30 / 2025.07.25

Morning Seminar 4

“Enhancing AAV Production Efficiency: A Dual Approach to DoE Optimization and Economic Feasibility Analysis”

Chair: Ryuichi Uozumi (Technology and Licensing, Revvity, Inc.)
Speaker: Igor Alves Mancilla（Process Development, Revvity Gene Delivery, Revvity, Inc.）
Co-sponsor: Revvity, Inc.

Hall 2 / 08:45-09:30 / 2025.07.25

Morning Seminar 5

Chair: Takuma Iwasaki (Field Application Scientist, Unchained Labs)
Speakers: “Exploration of Efficient AAV Vector Production Strategies”; Mikako Wada (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo); “AAV vectors: expansion of research and standardization”; Hiroaki Mizukami (Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University)
Co-sponsor: Unchained Labs

Hall 3 / 08:45-09:30 / 2025.07.25

Morning Seminar 6

“TBD”

Chair: TBD
Speakers: TBD
Co-sponsor: lavita

Hall 1 / 11:10-12:10 / 2025.07.23

Luncheon Seminar 1

“TBD”

Chair: TBD
Speakers: TBD
Co-sponsor: AnGes Inc.

Hall 2 / 11:10-12:10 / 2025.07.23

Luncheon Seminar 2

“The innovation imperative: driving the evolution of genomic medicine”

Chair: Naohito Hariganeya（Genomic Medicine Viral Vector Workflows, Cytiva）
Speakers: Marc Bisschops (Genomic Medicine, Cytiva); Peiqing Zhang (Genomic Medicine, Cytiva)
Co-sponsor: Cytiva

Hall 3 / 11:10-12:10 / 2025.07.23

Luncheon Seminar 3

Chair: Yuji Tsunekawa (The Institute of Medical Science, The University of Tokyo)
Speakers: “Solid-state nanopore sensors for characterizing AAV vectors”; Makusu Tsutsui (SANKEN, The University of Osaka); “Advanced Chromatographic Techniques for Purification and Characterization of Full Capsid AAV Vectors”; Kouhei Yoshida (Tosoh Corporation Life Science Research Laboratory)
Co-sponsor: Tosoh Corporation

Hall 1 / 11:40-12:40 / 2025.07.24

Luncheon Seminar 4

Chair: Takashi Okada (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Speakers: “Translational Research on Amnion MSCs for Muscular Dystrophy: From Bench to Bedside”; Yuko Kasahara (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo); “Enhancing the Safety of AAV Gene Therapy for DMD: Development of a Dose-Reduction Protocol Using AMSC Combination Therapy”; Hiromi Hayashita-Kinoh (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Co-sponsor: KANEKA CORPORATION

Hall 2 / 11:40-12:40 / 2025.07.24

Luncheon Seminar 5

“Gene Therapy for Genetic Disorders Using Engineered AAV Capsid”

Chair: Maki Tanaka (TAKARA BIO INC.)
Speaker: Toru Uchiyama (Division of Molecular Pathogenesis, Dept. of Human Genetics, National Center for Child Health and Development)
Co-sponsor: Takara Bio Inc.

Hall 3 / 11:40-12:40 / 2025.07.24

Luncheon Seminar 6

“TBD”

Chair: TBD
Speaker: Yoshikazu Yonemitsu (Kyushu University Graduate School of Pharmaceutical Sciences)
Co-sponsor: Miltenyi Biotec

Hall 1 / 11:55-12:55 / 2025.07.25

Luncheon Seminar 7

“Importance of Manufacturing Process and Quality Analysis thorough Development of AAV-based Gene Therapy Product”

Chair: Naoyuki Yamada (Synplogen Co., Ltd.)
Speakers: “AAV vector manufacturing and quality control for first in human study”; Susumu Uchiyama (Osaka University Graduate School of Engineering); “Gene Therapy Bio Foundry; Integrated Value Chain from DNA Design & Synthesis to Development of Manufacturing Process & Analytical Testing Method”; Kumiko Otsuki (Synplogen Co., Ltd.)
Co-sponsor: Synplogen Co., Ltd. / TAIYO PHARMA TECH CO., LTD.

Hall 2 / 11:55-12:55 / 2025.07.25

Luncheon Seminar 8

Chair: Mahito Nakanishi (TOKIWA Bio Inc.)
Speakers: “Development and Application of Stealth RNA Vector”; Mahito Nakanishi (TOKIWA Bio Inc.); “Progress in direct reprogramming research and its medical prospects”; Atsushi Suzuki (Medical Institute of Bioregulation, Kyushu University)
Co-sponsor: ROHTO Pharmaceutical Co.,Ltd.

Hall 3 / 11:50-12:20 / 2025.07.25

Luncheon Seminar 9-1

“Current Challenges and Our Approaches to Developing Best-in-Class rAAV Manufacturing Processes for Large-scale GMP Production”

Chair: TBD
Speaker: Liying Yang（PackGene）
Co-sponsor: PackGene Biotech INC.

Hall 3 / 12:25-12:55 / 2025.07.25

Luncheon Seminar 9-2

“Application study of Salt Tolerant Benzonase and AAV production”

Chair: Sadao Ozawa (Merck Ltd.)
Speaker: Yosuke Imamura (Merck Ltd.)
Co-sponsor: Merck Ltd.

Hall 1 / 15:15-16:15 / 2025.07.23

Afternoon Seminar 1

Chair: Yasuyuki Miyazaki (QIAGEN K.K.)
Speakers: “Quantitative and Digital PCR - Past, Present and the Future”; Mikael Kubista (Czech Academy of Science & Precision BioAnalytics, Sweden); “Verification of an AAV Vector Genome Quantification Method and DNA Extraction Efficiency for Biodistribution Studies Using Digital PCR”; Yurie Okawa (Shin Nippon Biomedical Laboratories, Ltd.)
Co-sponsor: QIAGEN K.K.

Hall 2 / 15:15-16:15 / 2025.07.23

Afternoon Seminar 2

“Advancing Cell Therapy and Viral Vector Manufacturing”

Chair: Shin Kawamata (Cyto-Facto Inc.)
Speakers: “Advancing the Manufacturing of "my iPS" Cells Using a Closed Automated Cell Processing System”; Masayoshi Tsukahara (Research and Development Center, CiRA Foundation); “Addressing challenges in viral vector production: Innovations to accelerate development, improve scalability, and reduce cost of goods”; Natasha Serzedello (Thermo Fisher Scientific); “Platformable AAV virus vector purification solution”; Haruna Tomotake (Bioproduction Division, Life Technologies Japan Ltd.)
Co-sponsor: Life Technologies Japan Ltd.

Hall 3 / 15:15-16:15 / 2025.07.23

Afternoon Seminar 3

“Advancing Cell and Gene Therapies Through Non-Viral Engineering Modalities”

Chair: Lucy Yang (MaxCyte, Inc.)
Speakers: Masahisa Ohishi (MaxCyte, Inc.); Peter Gee (MaxCyte, Inc.)
Co-sponsor: MaxCyte, Inc.

Hall 1 / 15:35-16:35 / 2025.07.24

Afternoon Seminar 4

“Efforts Toward GMP-Compliant AAV Vector Manufacturing in Academia”

Chair: Yui Harada (Graduate School of Pharmaceutical Sciences, Kyushu University)
Speaker: Mikako Wada (Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Co-sponsor: FUKOKU CO., LTD

Hall 2 / 15:35-16:35 / 2025.07.24

Afternoon Seminar 5

“Importance of Newborn Screening for Therapeutic Strategy with Gene Therapy and Stem Cell Transplantation”

Chair: Fumio Endo (Kumamoto-Ezuko Medical Center for the Severely Disabled)
Speaker: Shirou Matsumoto (Dept. of Neonatology, Kumamoto University Hospital)
Co-sponsor: KM Biologics Co., Ltd.

Hall 3 / 15:35-16:35 / 2025.07.24

Afternoon Seminar 6

Chair: Shin Adachi (Bio-Rad Laboratories K.K.)
Speakers: “The Impact of Droplet Digital PCR on Gene and Cell Therapy Development”; Yukinori Yatsuda (Bio-Rad Laboratories K.K.); “Application of ddPCR in Quality Evaluation of Gene Therapy Products: Considerations for Ensuring Measurement Stability”; Takenori Yamamoto (Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences)
Co-sponsor: Bio-Rad Laboratories, Inc.

Hall 1 / 14:55-15:40 / 2025.07.25

Afternoon Seminar 7

Chair: Susumu Uchiyama (Dept. of Biotechnology, Graduate School of Engineering, The University of Osaka)
Speakers: “Towards the Development and Provision of Optimal Media for AAV”; Takahiro Katayama (AJINOMOTO CO., INC); “Fueling the Future of AAV Gene Therapies with Manufacturing Innovation”; Rachael Hardison (AJINOMOTO CO., INC)
Co-sponsor: AJINOMOTO CO., INC

Hall 2 / 14:55-15:40 / 2025.07.25

Afternoon Seminar 8

“TBD”

Chair: TBD
Speakers: TBD
Co-sponsor: TBD

Hall 3 / 14:55-15:40 / 2025.07.25

Afternoon Seminar 9

“Utilization of tangential flow filtration filters in AAV clarification process”

Chair: Hiroki Fukutomi (ASAHI KASEI LIFE SCIENCE CORPORATION)
Speaker: Ryosuke Koide (ASAHI KASEI LIFE SCIENCE CORPORATION)
Co-sponsor: ASAHI KASEI LIFE SCIENCE CORPORATION

Hall 3 / 16:25-17:10 / 2025.07.24

Afternoon Seminar 10

“Exploring the advantages of lipid-based gene delivery for CAR-T and CAR-NK cell therapy”

Chair: Ryosuke Fujimori (Sartorius Stedim Group)
Speaker: Ian Villamagna (Sartorius Stedim Group)
Co-sponsor: (Sartorius Stedim Group)

Hall 1 / 18:00-18:45 / 2025.07.23

Evening Seminar 1

“Gene therapy with blood-brain barrier-penetrating AAV”

Chair: Kenichi Kashimada (Division of Endocrinology and Metabolism, National Center for Child Health and Development)
Speaker: Hiroyuki Sonoda (JCR Pharmaceuticals Co., Ltd.)
Co-sponsor: JCR Pharmaceuticals Co., Ltd.

Hall 2 / 18:00-18:45 / 2025.07.23

Evening Seminar 2

“Advancing AAV production in combination with our large-scale AAV capsid evolution and high-throughput antibody screening”

Chair: Masafumi Onodera (Graduate School of Engineering, Osaka University)
Speaker: Miho Matakatsu (VectorBuilder Japan Inc.)
Co-sponsor: VectorBuilder Inc.

Hall 3 / 18:00-18:45 / 2025.07.23

Evening Seminar 3

Chair: Takashi Okada (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Speakers: “Algal lectins open up new technological developments-Applications in medicine of highly accurate glycan recognition ability-”
Kanji Hori（Hiroshima University, The IT Lab）; “Analysis of AAV Capsid Surface Glycosylation for Development of a Purification Strategy”
Mikako Wada (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Co-sponsor: The IT Lab Co.,Ltd.

Hall 1 / 17:35-18:20 / 2025.07.24

Evening Seminar 4

“Development trends and prospects for CAR-T therapy”

Chair: Yozo Nakazawa (Dept. of Pediatric, Shinshu University School of Medicine)
Speaker: Shigeki Yagyu (Innovative Research & Liaison Organization, Shinshu University / A-SEEDS Co., Ltd.)
Co-sponsor: MediRidge Co.,Ltd. / TEIJIN REGENET CO., LTD.

Hall 2 / 17:35-18:20 / 2025.07.24

Evening Seminar 5

“Collaboration between CiRA Foundation and Terumo BCT: toward automation of iPSC expansion and differentiation”

Chair: Masahiro Kino-oka (Dept. of Biotechnology, Graduate School of Engineering, The University of Osaka)
Speaker: Masayoshi Tsukahara (CiRA Foundation)
Co-sponsor: Terumo BCT, Inc.

Hall 3 / 17:35-18:20 / 2025.07.24

Evening Seminar 6

“A novel approach to developing cell therapies”

Chair: Takashi Torashima (FUJIFILM Wako Pure Chemical Corporation)
Speakers: Shinichi Hashimoto (Bio Science & Engineering Laboratories, FUJIFILM Corporation); Yuki Kagoya (Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University School of Medicine)
Co-sponsor: FUJIFILM Wako Pure Chemical Corporation

Presidential Lecture

Invited Lecture

Special Lecture

Educational Lecture

Special Program

ASGCT/ESGCT/JSGCT Joint Symposium

Joint Program

Symposia

Plenary Session

Takara Bio Research Award 2025

Reports on the ESGCT Spring School 2025

Oral Session

Poster Session

AMED Support Programs for Clinical Development of Regenerative Medicine, Cell Therapy, and Gene Therapy

Co-sponsored Seminars